Filing Details

Accession Number:
0000711377-10-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-04 07:10:25
Reporting Period:
2010-09-29
Filing Date:
2010-10-04
Accepted Time:
2010-10-04 07:10:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-29 2,340 $8.18 12,614 No 4 M Direct
Common Stock Disposition 2010-09-29 2,340 $34.39 10,274 No 4 S Direct
Common Stock Acquisiton 2010-09-29 268 $9.02 10,542 No 4 M Direct
Common Stock Disposition 2010-09-29 268 $34.39 10,274 No 4 S Direct
Common Stock Acquisiton 2010-09-30 1,457 $9.02 11,731 No 4 M Direct
Common Stock Disposition 2010-09-30 1,457 $34.11 10,274 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right to buy) Disposition 2010-09-29 2,340 $0.00 2,340 $8.18
Common Stock Common Stock Option (Right to buy) Disposition 2010-09-29 268 $0.00 268 $9.02
Common Stock Common Stock Option (Right to buy) Disposition 2010-09-30 1,457 $0.00 1,457 $9.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
47,045 2010-10-31 No 4 M Direct
46,777 2011-11-03 No 4 M Direct
45,320 2011-11-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,564 Indirect Held by Neogen 401-K Plan
Footnotes
  1. The options were granted 10/31/05 as ISO options and became exercisable 20% yearly thereafter
  2. The options were granted 11/3/06 as ISO options and became exercisable 20% yearly thereafter